ClinicalTrials.gg
Active, not recruitingNCT03849586PHOENIXUpdated Jun 16, 2026

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

An observational study in Erectile Dysfunction, sponsored by European Association of Urology Research Foundation. Active, not recruiting at 30 sites in 8 countries. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by European Association of Urology Research Foundation · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,076
Ages
18 Years and older
Sex
Male
01

Study summary

Prospective collection of pre-defined parameters on the surgical treatment of male erectile dysfunction using Penile Prosthesis Implants (PPIs).

Read the detailed description

This will be a prospective collection of pre-defined parameters on the surgical treatment of male erectile dysfunction using Penile Prosthesis Implants (PPIs). The data collection will be undertaken from multiple centres in Europe. The participation will be by open invitation from the European Association of Urology (EAU) Section of Genitourinary Reconstructive Surgeons (ESGURS) to all its members, along with other urologists undertaking these procedures.

There will be no restriction on the number of patients enrolled per centre as long as they are consecutive. The aim is to have a long term collection of the dataset from as many centres as possible. An initial assessment for the robustness of the data collection and first clinical evaluation of the data collected will be performed 1 and 2 years after recruitment of the first patient by a nominated steering committee. Thereafter, the evaluations will be performed every 2 years until the end of Registry (10 years after the first patient was enrolled).

02

Conditions studied

  • Erectile Dysfunction

Browse trials for

Keywords

  • penile prosthesis implant
03

In context

Erectile Dysfunction

701 studies on the registry are indexed under Erectile Dysfunction; 125 are open to participants now.

This study's enrollment of 1,076 is above the median of 130 across 125 observational studies indexed under Erectile Dysfunction.

Browse Erectile Dysfunction studies →

Lead sponsor

European Association of Urology Research Foundation is the lead sponsor of 10 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Male patients undergoing a surgical Penile Prosthesis Implant for treatment of erectile dysfunction.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male patient undergoing a surgical penile prosthesis implant for treatment of erectile dysfunction.
  • Participant is willing and able to give for participation in the Registry and is able to complete the questionnaires.

Exclusion criteria

Exclusion Criteria:

  • Participating center is unable to contribute consecutive patients.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,076 participants (actual)
Target follow-up
10 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Patient Satisfaction score

    Patient Satisfaction score is defined as the mean patient satisfaction score as indicated by the Modified Patient EDITS Questionnaire. All items on the Patient EDITS will be scored from zero (no satisfaction or dissatisfaction) to four (high satisfaction). The mean satisfaction score for each patient will be calculated. To place scores in an easily interpretable metric, each mean score will be multiplied by 25 so that EDITS scores could range from a low of 0 (extremely low treatment satisfaction) to a high of 100 extremely high treatment satisfaction).

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

Secondary outcomes

  1. Partner Satisfaction score

    Partner Satisfaction score is defined as the mean partner satisfaction score as indicated by the Modified Partner EDITS Questionnaire. All items on the Partner EDITS will be scored from zero (no satisfaction or dissatisfaction) to four (high satisfaction). The mean satisfaction score for the partner will be calculated. To place scores in an easily interpretable metric, each mean score will be multiplied by 25 so that EDITS scores could range from a low of 0 (extremely low treatment satisfaction) to a high of 100 extremely high treatment satisfaction).

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  2. Patient satisfaction rate

    The number of patients with an EDITS score ≥ 50 compared to the total number of patients

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  3. Partner satisfaction rate

    The number of partners with an EDITS score ≥ 50 compared to the total number of partners

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  4. Overall time being satisfied with treatment since implantation

    The interval from the date of regaining a patient EDITS score of 50 or more until the time of EDITS score of less than 50

    Time frame: up to 10 years post surgery

  5. International Index of Erectile Function - 5 (IIEF short form/SHIM) questionnaire

    The IIEF-5 score is the sum of the ordinal responses to five items; thus, the score can range from 0 to 25. Erectile Dysfunction (ED) severity can be classified into the following five categories based on IIEF-5 scores; severe (0-7), moderate (8-11), mild to moderate (12-16), mild (17-21), and no ED (22- 25). Mean IIEF-5 scores will be calculated at the indicated time points and numbers / percentages of patients in the different ED severity categories. Also change in IIEF-5 score compared to baseline will be calculated.

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  6. Sexual Encounter Profile (SEP) questions 2 and 3

    For SEP question 2 and 3, scores are percentage of yes responses relative to number of sexual attempts/encounters. Proportions of yes responses will be treated as continuous variables. Post-operative results will also be compared to baseline.

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  7. EQ-5D-5L quality of life questionnaire

    Results of the EQ-5D-5L quality of life questionnaire will be analyzed as described in the EuroQol EQ-5D-5L user guide. Post-operative results will also be compared to baseline.

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  8. Quality of Life and Sexuality with Penile Prosthesis (QoLSPP) questionnaire

    QoLSPP is a 16-item questionnaire, with 4 domains: the functional, relational, social and personal domain. Responses are structured according to a six-point Likert scale, in most cases ranging from "never" (0) to "always" (5), where higher values represent more positive responses. Individual item scores will be analyzed as well as domain scores.

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

  9. Complications

    Type of complications, associated symptoms and whether or not a revision was needed will be recorded.

    Time frame: during surgery and up to 10 years after surgery

  10. Immediate Postoperative complications

    Type of complications, associated symptoms and whether or not a revision was needed will be recorded and classified according to the Clavien Dindo grading system.

    Time frame: until 2 weeks after surgery

  11. Time of first activation, first cycling, first use, first intercourse, first orgasm, if applicable

    The date of first cycling (inflating and deflating the prosthesis several times), the date of first activation and first use for sexual activity, the date of first sexual intercourse and the date of first orgasm, if applicable, will be reported.

    Time frame: up to 10 years post surgery

  12. Time being revision-free

    The interval from the date of surgery to the date of revision whereby revision is defined as any urogenital surgical intervention that is related to the function, placement, or site reaction to the implanted device

    Time frame: up to 10 years post surgery

  13. Revision-free rate

    The number of patients who are revision-free compared to the total number of patients.

    Time frame: at 1, 2, 4, 6, 8 and 10 years of Registry follow-up

07

Study locations

30 sites
08

References and documents

Publications

  • van Renterghem K, Deho F. Perspective on the PHOENIX trial: prospective registry for patients undergoing penile prosthesis implantation for male erectile dysfunction in multiple European centers. Int J Impot Res. 2023 Jun;35(4):329-331. doi: 10.1038/s41443-022-00547-7. Epub 2022 Feb 26. No abstract available. PubMed 35220417 ↗
  • Caris C, Timmerman H, Witjes W, van Renterghem K, Deho F, Pescatori E, Utizi L, Caraceni E. The quality of life and sexuality with penile prosthesis questionnaire. A translation and cross-cultural adaptation into multiple languages. J Sex Med. 2026 Mar 9;23(4):qdag069. doi: 10.1093/jsxmed/qdag069. No abstract available. PubMed 41838870 ↗
  • van Renterghem K, Jorissen C, Van Huele A. Penile length changes after penile implant surgery. J Sex Med. 2023 Nov 30;20(12):1364-1366. doi: 10.1093/jsxmed/qdad125. No abstract available. PubMed 38037429 ↗
  • Van Renterghem K, De Bruyn H, Yebes A, Calopedos R, Deho F, Torremade J, D'Anna M, Bettocchi C, Gomez BG, Caris C, Witjes W, Moncada I, Ralph D; EAU Research Foundation PHOENIX Study Group. Early complications after penile prosthesis surgery: findings from the PHOENIX multicenter registry. Int J Impot Res. 2026 Jan;38(1):30-36. doi: 10.1038/s41443-025-01080-z. Epub 2025 May 7. PubMed 40335744 ↗
  • Van Renterghem K, Yebes A, Lamers G, Torremade J, Bettocchi C, Garcia-Gomez B, Lee WG, Caris C, Witjes W, Moncada I, Ralph D; EAU Research Foundation PHOENIX Study Group. Predictors of penile prosthesis length: results from the PHOENIX registry. Int J Impot Res. 2026 Jun 1. doi: 10.1038/s41443-026-01294-9. Online ahead of print. PubMed 42225959 ↗

Individual participant data

Plan to share: Undecided — Investigators may share anonymized individual data with residents/urologist interested to analyze and publish the results of the registry

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03849586
Lead sponsor
European Association of Urology Research Foundation
Responsible party
Sponsor
First posted
Feb 21, 2019
Start date
Nov 19, 2021
Primary completion
Feb 2032 (estimated)
Completion
Feb 2032 (estimated)
Last update
Jun 16, 2026

Study contacts

Koen van Renterghem, MD, PhD
principal investigator · Jessa Hospital, Hasselt, Belgium

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion